Back to Results
First PageMeta Content
Amines / Amides / Antidotes / Deferoxamine / Thalassemia / Beta-thalassemia / Methadone / Chelation therapy / Compliance / Chemistry / Medicine / Organic chemistry


An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use Alexandra Ward PhD MRPharmS1, J. Jaime Caro MDCM1,2, Traci Craig Green BA1, Krista Huybrechts MS1,
Add to Reading List

Open Document

File Size: 231,56 KB

Share Result on Facebook

City

Barcelona / Montréal / Concord / Basel / Hounslow / /

Company

Novartis Pharma AG / Spain 4 Previously Novartis Pharma AG / Canada 3 Novartis Pharmaceutica S.A. / Abstract Background Management / Bristol-Myers Squibb / /

Country

Taiwan / Switzerland / Italy / Cyprus / Iran / Egypt / Jordan / United States / United Kingdom / Greece / India / /

/

Facility

Androulla Eleftheriou PhD5 Caro Research Institute / Caro Research Institute / Royal Victoria Hospital / McGill University / /

/

IndustryTerm

study protocol / /

MedicalCondition

chronic preventive regimens / thalassemia major / chronic treatment regimens / thalassemia / illness / MS / hypertension / chronic regimens / thalassemia association / diseases / /

MedicalTreatment

chelation therapy / blood transfusion / renal transplantations / blood transfusions / natural remedies / bone marrow transplants / /

Organization

Royal Victoria Hospital / Androulla Eleftheriou PhD5 Caro Research Institute / Caro Research Institute / Thalassemia International Federation / McGill University / USA Division of General Internal Medicine / Thalassemia International Foundation / /

Person

J. Jaime Caro / Alejandro Arana / Krista Huybrechts / Traci Craig Green / Suzanne Wait / Jaime Caro / Androulla Eleftheriou / /

/

Position

Contributions Author / physician / Author / representative / /

ProvinceOrState

Massachusetts / /

Technology

study protocol / /

SocialTag